| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2023 | Dec 5, 2023 | Immunovant, Inc. | Director | Sell | 22.5 | -12,700 | -10.37% | ✓ | $504.6K |
| Aug 20, 2021 | Aug 20, 2021 | Immunovant, Inc. | Director | Buy | 95.0 | +7,000 | 11.63% | ✗ | $53.6K |